Inhaler
Latest AstraZeneca AB Patents:
- Amido heteroaromatic compounds
- Methods of delaying pain progression and treating prostate cancer
- Methods of treating chronic kidney disease with dapagliflozin
- PHARMACEUTICAL COMPOSITIONS COMPRISING (2S)-N-{(1S)-1-CYANO-2-[4-(3-METHYL-2-OXO-2,3-DIHYDRO-1,3-BENZOXAZOL-5-yl)PHENYL]ETHYL}-1,4- OXAZEPANE-2-CARBOXAMIDE
- Compositions and methods of treating cancer with chimeric antigen receptors
Description
FIG. 1 is a perspective view of the inhaler;
FIG. 2 is a bottom elevation of the inhaler;
FIG. 3 is a rear elevation of the inhaler;
FIG. 4 is a top elevation of the inhaler;
FIG. 5 is a side elevation of the inhaler; and,
FIG. 6 is a front elevation of the inhaler.
Claims
The ornamental design for an inhaler, as shown and described.
Referenced Cited
Patent History
Patent number: D449882
Type: Grant
Filed: Sep 25, 2000
Date of Patent: Oct 30, 2001
Assignee: AstraZeneca AB (Sodertalje)
Inventors: Søren Christrup (Struer), Anders Geert-Jensen (Höjberg), Mikal Jørgensen (Århus), Jørgen Rasmussen (Struer), Hugo Dines Schmidt (Århus)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Nixon & Vanderhye
Application Number: 29/129,874
Type: Grant
Filed: Sep 25, 2000
Date of Patent: Oct 30, 2001
Assignee: AstraZeneca AB (Sodertalje)
Inventors: Søren Christrup (Struer), Anders Geert-Jensen (Höjberg), Mikal Jørgensen (Århus), Jørgen Rasmussen (Struer), Hugo Dines Schmidt (Århus)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Nixon & Vanderhye
Application Number: 29/129,874
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)
International Classification: 2902;
International Classification: 2902;